Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
6.19
-0.02 (-0.32%)
At close: Sep 17, 2025, 4:00 PM EDT
6.19
0.00 (0.00%)
After-hours: Sep 17, 2025, 4:10 PM EDT
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $157.58 million as of September 17, 2025. Its market cap has increased by 24.42% in one year.
Market Cap
157.58M
Enterprise Value
130.78M
1-Year Change
24.42%
Ranking
Category
Stock Price
$6.19
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $157.58M, an increase of 171.66%. That is a compound annual growth rate of 31.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 158.09M | 51.24% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |